Global Preventable Vaccines Market Growth, Share, Size, Trends and Forecast (2022 - 2028)
Segmented by Type of Vaccine;
Live Attenuated Vaccine, Killed Vaccine, Toxoid Vaccine and Genetically Modified/Engineered Vaccine.Segmented by Product Type;
Polysaccharide Vaccines and Conjugate Vaccines.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).Introduction
Global Preventable Vaccines Market (USD Million), 2018 - 2028
# | Global |
---|---|
2018 | 75.5 |
2019 | 84.0 |
2020 | 92.9 |
2021 | 97.9 |
2022 | 112.6 |
2023 | 131.6 |
2024 | 133.0 |
2025 | 149.1 |
2026 | 175.7 |
2027 | 207.8 |
2028 | 239.2 |
In the year 2021, the Global Preventable Vaccines Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%.
Global Preventable Vaccines Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Preventable Vaccines Market |
Study Period | 2018 - 2028 |
Base Year (for Preventable Vaccines Market Size Estimates) | 2021 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Preventable Vaccines Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns). Call center market size by region or country xxxx revenue of office administrative and business support in italy xxxx, by sector call centers market revenue share in china xxxx-xxxx, by segment. The global edible oil and fats market size was valued at usd xx.xx billion in xxxx. The sodium bicarbonate market is expected to witness market growth at a rate of approximately 5.10% in the forecast period of xxxx to xxxx is expected to reach usd xxx.xx million by xxxx. The sustainability management software market share is expected to increase by usd xxx.xx million from xxxx to xxxx, at an accelerated cagr of 11.93%, according to the recent market study. The global compost market size will reach usd xxxx.x million in xxxx, growing at a cagr of 4.0% over the analysis period.
Global Preventable Vaccines Market Analysis
Global preventable vaccines market is expected to gain market growth in the forecast period of xxxx to xxxx. The market is growing at a healthy cagr in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The global preventable vaccines market is majorly driven by high incidence of chronic condition such as flu and bacterial infections diseases and launch of newer vaccine annually. Furthermore, presence of large immunization programs and increase healthcare expenditure are considered a positive factor that drives the market growth. Nevertheless, scarcity of trained expertise or technically skilled professionals for the development of preventable vaccines coupled with high treatment cost significantly hinder the growth of this market. In this report, the global preventable vaccines market has been segmented by type of vaccine, product type and geography.
Global Preventable Vaccines Market, Segmentation by Type of Vaccine
The Global Preventable Vaccines Market has been segmented by Type of Vaccine into Live Attenuated Vaccine, Killed Vaccine, Toxoid Vaccine and Genetically Modified/Engineered Vaccine. The complete Global Preventable Vaccines Market segmentation by Type of Vaccine can be seen below:
- Global Preventable Vaccines Market, By Type of Vaccine
- Live Attenuated Vaccine
- Killed Vaccine
- Toxoid Vaccine
- Genetically Modified/Engineered Vaccine
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Type of Vaccines mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Type of Vaccine is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Preventable Vaccines Market, by Type of Vaccine (USD Million), 2018 - 2028
# | Live Attenuated Vaccine | Killed Vaccine | Toxoid Vaccine | Genetically Modified/Engineered Vaccine |
---|---|---|---|---|
2018 | 117.2 | 63.0 | 66.9 | 64.2 |
2019 | 118.4 | 63.9 | 75.4 | 76.8 |
2020 | 140.2 | 74.7 | 85.8 | 83.3 |
2021 | 144.9 | 77.4 | 90.4 | 92.6 |
2022 | 169.6 | 80.0 | 104.3 | 105.7 |
2023 | 178.4 | 91.6 | 111.3 | 110.2 |
2024 | 195.0 | 104.7 | 129.4 | 127.1 |
2025 | 213.0 | 110.0 | 146.1 | 142.7 |
2026 | 215.9 | 119.8 | 166.4 | 161.5 |
2027 | 255.5 | 135.2 | 172.6 | 180.5 |
2028 | 267.7 | 145.4 | 178.7 | 193.4 |
Global Preventable Vaccines Market, Segmentation by Product Type
The Global Preventable Vaccines Market has been segmented by Product Type into Polysaccharide Vaccines and Conjugate Vaccines. The complete Global Preventable Vaccines Market segmentation by Product Type can be seen below:
- Global Preventable Vaccines Market, By Product Type
- Polysaccharide Vaccines
- Conjugate Vaccines
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Product Types mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Product Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Preventable Vaccines Market, by Product Type (USD Million), 2018 - 2028
# | Polysaccharide Vaccines | Conjugate Vaccines |
---|---|---|
2018 | 59.2 | 77.3 |
2019 | 66.3 | 80.8 |
2020 | 76.4 | 86.5 |
2021 | 90.8 | 102.5 |
2022 | 101.8 | 103.5 |
2023 | 102.9 | 105.9 |
2024 | 103.7 | 113.4 |
2025 | 106.6 | 121.3 |
2026 | 114.5 | 137.3 |
2027 | 122.0 | 149.5 |
2028 | 143.7 | 176.9 |
Global Preventable Vaccines Market, Segmentation by Geography
In this report, the Global Preventable Vaccines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Preventable Vaccines Market Share (%), by Geographical Region, 2021
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Preventable Vaccines Market in all the Regions and Countries (specified above) for historic (2018 - 2021) and forecast (2022 - 2028) Periods with 2021 considered as the base year.
This report also provides an analysis of why the market size of Preventable Vaccines in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Preventable Vaccines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Preventable Vaccines Market is driven by; Inclusion in NIP.
- The factors hindering the growth of Global Preventable Vaccines Market will be discussed in detail in the full report.
- The new opportunities in Global Preventable Vaccines Market will be discussed in detail in the full report.
- Inclusion in NIP.
- Global Preventable Vaccines Market Restraints will be discussed in detail in the full report.
- Global Preventable Vaccines Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Preventable Vaccines Market. The opportunity map (by market segments; Type of Vaccine and Product Type) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Preventable Vaccines Market, Opportunity Map, By Region (2018 - 2028)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Preventable Vaccines Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Preventable Vaccines Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Preventable Vaccines Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Global preventable vaccines market uses mayonnaise market, ossotide market, smartwatch market, earbuds market, pharmacy retail market, nemt market, animal feed market, piezoelectric sensor market, perfume market, drink alcoholic beverages market, digital content market, plywood industry, energy management systems market, air purifier market, snack brands market, sanitary ware industry, sanitary pad market, mobile accessories market and petrochemicals market.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Preventable Vaccines Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Preventable Vaccines Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Preventable Vaccines Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Preventable Vaccines Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Preventable Vaccines Market include, GlaxoSmithKline, Merck, Novartis, Pfizer and Sanofi.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type of Vaccine
- Market Snapshot, By Product Type
- Market Snapshot, By Region
- Market Opportunity Map
- Global Preventable Vaccines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Inclusion in NIP
- Restraints
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Preventable Vaccines Market, By Type of Vaccine, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Live Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Killed Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Genetically Modified/Engineered Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Live Attenuated Vaccine
- Global Preventable Vaccines Market, By Product Type, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Polysaccharide Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Polysaccharide Vaccines
- Global Preventable Vaccines Market, By Geography, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Vaccine, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
- GCC
- North America
- Global Preventable Vaccines Market, By Type of Vaccine, 2020 - 2030 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- GlaxoSmithKline
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Merck
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Sanofi
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- GlaxoSmithKline
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2021, the Global Preventive Asthma Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Prils Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Primary Aldosteronism Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Primary Biliary Cholangitis (PBC) Therapeutics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%